NASDAQ:CFMS
Delisted
ConforMIS Stock News
$2.26
+0 (+0%)
At Close: Nov 30, 2023
Conformis Announces Full Commercial Launch of Imprint™
12:00pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) Conformis’ Imprint™ knee system introduces the new “Made-to
Conformis, Inc. Announces Settlement of Medacta Patent Litigation
09:15pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Conformis Settles Medacta Litigation Related to Patient-Specific Instruments Conformis Settles Medacta Litigation Related to Patient-Specific Instruments
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
10:10am, Friday, 11'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions relat
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
10:12am, Thursday, 10'th Nov 2022 Benzinga
Gainers
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac
ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates
11:25pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Conformis, Inc. (CFMS) Q3 2022 Earnings Call Transcript
09:59pm, Wednesday, 02'nd Nov 2022
Conformis, Inc. (NASDAQ:CFMS ) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer Conference Call Participan
ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates
09:04pm, Wednesday, 02'nd Nov 2022
ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
UBS has released its annual house price bubble report. Here are the most overvalued markets.
12:43pm, Thursday, 20'th Oct 2022 MarketWatch
The arrival of the seventh annual UBS global real estate bubble report rings different, coming at the start of a period of retreat rather than during a wave of excess.
Who's going to be the next world's economic power? Here's what this famed economist is now saying — and one possible surprise
12:34pm, Monday, 17'th Oct 2022 MarketWatch
A new research paper circulated by the National Bureau of Economic Research asks a fascinating question -- which region will come to dominate the world economy?
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
08:30pm, Wednesday, 05'th Oct 2022 GlobeNewswire Inc.
BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
04:30pm, Wednesday, 05'th Oct 2022
BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it wi
US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
09:57am, Wednesday, 14'th Sep 2022 Benzinga
Pre-open movers
U.S. stock futures traded higher in early pre-market trade on Wednesday after recording sharp losses on Tuesday following the release of inflation data for August. All the three major
BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday
09:19am, Wednesday, 14'th Sep 2022 Benzinga
With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects BRP Inc. (NASDAQ: DOOO) to report quarterly
Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
08:30pm, Tuesday, 13'th Sep 2022 GlobeNewswire Inc.
New design adds increasingly more common tri-taper femoral stem design and direct anterior approaches to the expanding Conformis family of Personalized Total Hip Arthroplasty implants New design adds
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
08:30pm, Monday, 29'th Aug 2022 GlobeNewswire Inc.
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today th